Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Preclinical Development: Overview01:28

Preclinical Development: Overview

5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

279
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
279
Drug Regulation01:25

Drug Regulation

2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

A HORSESHOE MIXTURE MODEL FOR BAYESIAN SCREENING WITH AN APPLICATION TO LIGHT SHEET FLUORESCENCE MICROSCOPY IN BRAIN IMAGING.

The annals of applied statistics·2026
Same author

Astrocytes connect specific brain regions through plastic networks.

Nature·2026
Same author

Drug Development.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Transferrin receptor-binding blood-brain barrier shuttle enhances brain delivery and plaque-clearing efficacy of a therapeutic anti-Aβ antibody.

Fluids and barriers of the CNS·2025
Same author

Npas4 drives the effects of early social isolation on social behaviors and prefrontal parvalbumin neurons.

Progress in neurobiology·2025
Same author

The psychoplastogen tabernanthalog induces neuroplasticity without proximate immediate early gene activation.

Nature neuroscience·2025
Same journal

Evidence for progressive neurodegeneration in iatrogenic cerebral amyloid angiopathy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Human brain connectome profiles mediate the relationship between pathology burden and clinical phenotypes in Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Kat5 cKO mouse replicates biological domain signatures associated with Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Evaluation of CSF and plasma tau species as fluid surrogate candidates for tau PET in prodromal to moderate Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Associations of self-reported obstructive sleep apnea with cognition and dementia risk in cognitively unimpaired middle-aged adults.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Inflammation profiles in Alzheimer's disease relate to cognition and neurodegeneration.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Ver todos los artículos relacionados
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K

Desarrollo de Fármacos

Chase Redd1, Nathaniel Guanzon1, Yessenia Gallegos1

  • 1Translucence Biosystems, Inc, Irvine, CA, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
PubMed
Resumen
Este resumen es generado por máquina.

La aclaración de tejidos y la microscopía de lámina de luz permiten la obtención de imágenes de todo el cerebro de la biodistribución de anticuerpos terapéuticos en modelos preclínicos. Esta tecnología permite la cuantificación precisa de la entrega de fármacos y la interacción con el objetivo en el cerebro, ayudando al desarrollo de terapias para el SNC.

Palabras clave:
aclaración de tejidosmicroscopía de lámina de luzbiodistribución de anticuerposbarrera hematoencefálicadesarrollo de fármacos para el SNC

Más Videos Relacionados

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

451

Videos de Experimentos Relacionados

Last Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K
In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

451

Área de la Ciencia:

  • Neurociencia
  • Farmacología
  • Biotecnología

Sus antecedentes:

  • La histología tradicional requiere el corte de tejidos, lo que limita el análisis integral de órganos intactos.
  • La aclaración de tejidos ofrece a los neurocientíficos vistas completas y objetivas de la anatomía y función del cerebro.
  • La aclaración de tejidos es valiosa para el desarrollo de terapias para el SNC, ya que permite examinar la distribución de fármacos.

Objetivo del estudio:

  • Desarrollar y validar un pipeline para la medición a nivel celular y de todo el cerebro de la biodistribución terapéutica en modelos de roedores.
  • Evaluar la utilidad de la aclaración de tejidos para detectar anticuerpos terapéuticos que cruzan la barrera hematoencefálica (BHE) y se unen a objetivos del SNC.

Principales métodos:

  • Se utilizó un método de aclaración de tejidos basado en iDISCO combinado con microscopía de lámina de luz para la obtención de imágenes de cerebros de ratón intactos.
  • Se empleó un pipeline de cuantificación impulsado por IA para segmentar y medir la tinción de anticuerpos tanto en la vasculatura como en el parénquima cerebral.
  • Se investigó la entrega de anticuerpos utilizando tanto un anticuerpo biespecífico dirigido a BACE1 y TfR1, como un biosimilar de Donanemab en modelos de enfermedad de Alzheimer.

Principales resultados:

  • Un anticuerpo biespecífico cruzó la BHE y se unió a objetivos de BACE1 en el parénquima, mientras que un anticuerpo monospécifico no llegó al parénquima cerebral.
  • El pipeline de cuantificación midió con éxito los niveles parenquimales del anticuerpo biespecífico, distinguiéndolo de la señal vascular.
  • El biosimilar de Donanemab se acumuló en el cerebro de ratones modelo de EA, cruzando la BHE y localizándose con placas amiloides, a diferencia de los ratones de tipo salvaje.

Conclusiones:

  • Los métodos de aclaración de tejidos proporcionan una herramienta poderosa para el monitoreo cuantitativo de todo el cerebro de la biodistribución de anticuerpos terapéuticos.
  • Se demostró la capacidad de rastrear la entrega de terapias para el SNC y la unión a objetivos con resolución celular.
  • Se destaca el potencial de esta tecnología para avanzar en el desarrollo de terapias para la enfermedad de Alzheimer y la investigación preclínica.